Research on wound healing focuses on how complex cellular and molecular processes coordinate to repair damaged tissue, why healing sometimes fails, and how to improve outcomes.

Healing proceeds through overlapping phases. Hemostasis and inflammation occur first, as blood clotting and immune cells limit bleeding and clear debris. This is followed by proliferation, where fibroblasts lay down extracellular matrix, new blood vessels grow into the wound, and epithelial cells migrate to cover the surface. Finally, remodeling reorganizes collagen and other matrix components to strengthen the repaired tissue, although tensile strength rarely returns to pre injury levels.

A central theme is the role of the immune system. Neutrophils and macrophages are essential in early defense, but prolonged or dysregulated inflammation can impair healing. Macrophages in particular shift from a pro inflammatory to a pro regenerative phenotype, influencing scar formation, angiogenesis and matrix turnover.

Researchers also study chronic wounds and fibrosis. Chronic wounds, such as diabetic ulcers, are characterized by persistent inflammation, bacterial colonization, impaired angiogenesis and defective cell migration. In contrast, fibrotic healing results in excessive scar tissue with dense, disorganized collagen and loss of normal tissue architecture.

Key molecular regulators include growth factors, cytokines, extracellular matrix components and mechanical cues. Signaling pathways such as TGF beta, VEGF and others govern cell proliferation, migration and matrix deposition.

Therapeutic strategies aim to modulate these processes: controlling infection and inflammation, delivering growth factors or stem cells, using biomaterial scaffolds to guide tissue regeneration, and targeting molecular pathways that drive chronicity or fibrosis. The ultimate goal is functional, minimally scarred tissue repair.